VR Adviser’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $77M | Hold |
2,000,000
| – | – | 2.87% | 9 |
|
|
2025
Q4 | $71M | Sell |
2,000,000
-2,000,000
| -50% | -$56.2M | 3.51% | 8 |
|
|
2025
Q3 | $57.4M | Sell |
4,000,000
-755,411
| -16% | -$8.95M | 3.23% | 10 |
|
|
2025
Q2 | $34.1M | Sell |
4,755,411
-929,000
| -16% | -$5.15M | 2.56% | 11 |
|
|
2025
Q1 | $34M | Hold |
5,684,411
| – | – | 2.9% | 11 |
|
|
2024
Q4 | $44.3M | Buy |
5,684,411
+244
| +0% | +$2.43K | 3.04% | 11 |
|
|
2024
Q3 | $61.4M | Hold |
5,684,167
| – | – | 3.22% | 11 |
|
|
2024
Q2 | $47.9M | Buy |
5,684,167
+555,000
| +11% | +$4.21M | 3.05% | 12 |
|
|
2024
Q1 | $34.5M | Buy |
5,129,167
+445,000
| +10% | +$2.75M | 1.64% | 19 |
|
|
2023
Q4 | $27.5M | Hold |
4,684,167
| – | – | 1.89% | 16 |
|
|
2023
Q3 | $45.7M | Buy |
4,684,167
+35
| +0% | +$415 | 4.81% | 4 |
|
|
2023
Q2 | $55.5M | Sell |
4,684,132
-200,845
| -4% | -$2.3M | 8.87% | 2 |
|
|
2023
Q1 | $52.7M | Buy |
4,884,977
+846,860
| +21% | +$10.8M | 10.29% | 2 |
|
|
2022
Q4 | $46.7M | Hold |
4,038,117
| – | – | 7.86% | 4 |
|
|
2022
Q3 | $60.2M | Hold |
4,038,117
| – | – | 9.3% | 3 |
|
|
2022
Q2 | $36.4M | Buy |
4,038,117
+2,949,300
| +271% | +$20.1M | 7.17% | 5 |
|
|
2022
Q1 | $8.15M | Hold |
1,088,817
| – | – | 1.32% | 19 |
|
|
2021
Q4 | $9.34M | Hold |
1,088,817
| – | – | 1.28% | 20 |
|
|
2021
Q3 | $9.16M | Hold |
1,088,817
| – | – | 1.18% | 21 |
|
|
2021
Q2 | $8.83M | Hold |
1,088,817
| – | – | 1.07% | 23 |
|
|
2021
Q1 | $9.56M | Hold |
1,088,817
| – | – | 1.04% | 21 |
|
|
2020
Q4 | $12.2M | Sell |
1,088,817
-1
| -0% | -$11 | 1.8% | 16 |
|
|
2020
Q3 | $10.2M | Buy |
+1,088,818
| New | +$11.4M | 1.99% | 16 |
|
Other funds holding COGT
DM
VPM
VCM
FFM
RI
TCM